About Us : Who We Are
CELYSTRA Pharma is a Canadian, Quebec-based biopharmaceutical company focused on bringing innovative treatments to Canada.
Founded by three pharmaceutical veterans, CELYSTRA looks to identify innovative therapies developed internationally and through strategic partnerships accelerate their availability to underserved patient populations in Canada needing these the most.
With a strong understanding of the Canadian regulatory, access and reimbursement environments and a solid track record of launching and commercializing specialty and rare disease medicines, CELYSTRA aims to make a meaningful difference to Canadian patients.
Headquartered in Montreal CELYSTRA is an active contributor to the Quebec and Canadian life sciences ecosystems.
Our Mission
Closing the gap between breakthrough medicines and the patients who need these the most.
Our Approach
Innovation
Identifying and acquiring innovative therapies developed internationally.
Partnerships
Working with global partners to help bring new treatments to patients.
Access
Facilitating access in Canada to medicines that address unmet medical needs.
Our Focus
Bringing much needed innovative treatments to Canadian patients.
Partnerships
Accelerating access to patients.
We bring the know-how to effectively navigate partnered medicines through regulatory approval and Canada’s complex market access environment with a focus on commercial availability.